Purchase Order 75N98026P01509
Award Date 9/2/26
Potential Completion Date 9/1/27
Potential Value $24K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $100,491 firm-fixed price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) to Lonza Walkersville, Inc., a for-profit manufacturer of biological materials and laboratory supplies. The contract is for the delivery of up to 400 vials of cryopreserved No-Spin HepaRG cells, which are specialized cell lines used in toxicology research. This award supports a collaborative project between NIEHS and the Environmental...
- This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Life Technologies Corporation for the delivery of 50 vials of human spheroid-qualified hepatocytes. As described in the original solicitation, these liver cells will support the National Institute on Drug Abuse's Antiviral Program for Pandemics by enabling the continued identification of direct-acting antivirals and development of microphysiological systems...
- The National Institute of Environmental Health Sciences issued a purchase order to Lifenet Health on July 30, 2026, for $86,750 to supply human liver cells from donor tissues to support the Division of Translational Toxicology's mechanistic toxicology research. Performance takes place in Virginia Beach, Virginia, with ultimate completion by July 29, 2027. The procurement is firm fixed price with no set-aside designation. The order derives from a non-competitive solicitation posted July 6,...
- <p>The Food and Drug Administration awarded a purchase order to Bioivt, LLC for cryopreserved hepatocytes on August 17, 2023, with a ceiling value of $16,179.20. Performance is located in Silver Spring, Maryland. The order carries firm fixed price terms with an ultimate completion date of August 16, 2024.</p>
- This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
- <p>The Food and Drug Administration awarded a purchase order to Bioivt, LLC for metabolism-qualified cryopreserved human hepatocytes valued at $33,510.10 on July 30, 2026. This modification substitutes lot JLO with lot API. Performance occurs in Silver Spring, Maryland, with an ultimate completion date of January 29, 2027. The procurement is firm fixed price with no set-aside category.</p>
- <p>The Food and Drug Administration awarded a purchase order to Discovery Life Sciences, LLC for cryopreserved human hepatocytes, valued at $49,850.00, on June 14, 2023, under a Total Small Business set-aside. Place of performance is Huntsville, Alabama. The order, priced on a firm fixed-price basis, is due for completion by September 30, 2023.</p>
- This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of advanced 3D cell culture technologies. The $46,829.63 contract tasks Insphero with providing 3D liver microtissues composed of human primary hepatocytes and other liver cells, which are used for drug-induced liver injury assays and toxicity testing. These...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. and headquartered in Grand Island, New York, has been awarded a $48.9K firm fixed-price purchase order by the Food and Drug Administration (FDA) for cryopreserved human hepatocytes, with a completion date of September 24, 2026. The contract, awarded on September 19, 2025, with no set-aside designation, will be performed at the vendor's location in Grand Island, NY. Life Technologies Corporation is a leading supplier...
- This is a $90,414 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies and in vitro models. The contract is for a Liver Assay in Liver Spheroids to evaluate the toxicity of short interfering RNA (siRNA) and antisense oligonucleotides (ASOs), which are increasingly being used as...